Sickle Cell Disease Treatment Market Size And Share

  • Report Code : TIPRE00030312
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 245
Buy Now

Sickle Cell Disease Treatment Market Share, Analysis, and Growth by 2030

Buy Now

Sickle Cell Disease Treatment Market Report Sickle Cell Disease Treatment Market Scope and Analysis Sickle Cell Disease Treatment Market Size and Share

Sickle Cell Disease Treatment Market: Strategic Insights

Sickle Cell Disease Treatment Market

  • CAGR (2022 - 2030)
    19.1%
  • Market Size 2022
    US$ 1.16 Billion
  • Market Size 2030
    US$ 4.69 Billion

Market Dynamics

GROWTH DRIVERS
  • Increasing Prevalence of Sickle Cell Disease
  • Rising Initiatives to Raise Awareness about SCD
FUTURE TRENDS
  • Extending Pipeline of New Drugs and Vaccines
OPPORTUNITIES
  • Growing Strategic Initiatives by Market Players

Key Players

  • Novartis AG
  • Pfizer Inc
  • Emmaus Life Sciences Inc
  • Teva Pharmaceutical Industries Ltd
  • Bristol Myers Squibb Company
  • Siklos
  • Mylan NV
  • Taj Pharmaceuticals Limited
  • Apotex

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Treatment
  • Generic Drugs and Originators
Route of Administration
  • Oral andParenteral
Distribution Channel
  • Direct Tender
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies